デフォルト表紙
市場調査レポート
商品コード
1311128

ヘリコバクターピロリ診断の世界市場規模調査・予測:技術別、エンドユーザー別、地域別分析、2023-2030年

Global Helicobacter Pylori Diagnostics Market Size study & Forecast, by Technology (Immunoassays, POC, Molecular Diagnostics), by End User (Hospitals, Diagnostics Laboratories, Clinics), and Regional Analysis, 2023-2030

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヘリコバクターピロリ診断の世界市場規模調査・予測:技術別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年07月11日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘリコバクターピロリ診断の世界市場は、2022年に約6億120万米ドルと評価され、予測期間2023-2030年には6%以上の健全な成長率で成長すると予測されています。

ヘリコバクターピロリ診断市場とは、患者におけるヘリコバクターピロリ(H. pylori)菌の検出と同定のために特別に設計された診断検査および機器の利用に焦点を当てたセグメントを指します。これらの診断薬は、消化性潰瘍、胃炎、胃がんを含む様々な胃腸障害に関連するピロリ菌感染を特定する上で重要な役割を果たしています。ヘリコバクターピロリ市場は、血清学的検査、尿素呼気試験、便中抗原検査、分子診断などの様々な診断法を包含しており、医療従事者の正確でタイムリーな診断を支援し、ピロリ菌に関連する疾患の適切な治療と管理を可能にします。ヘリコバクターピロリ診断市場は、有病率の上昇やピロリ菌感染に関する意識の高まりといった要因によって牽引されています。

ヘリコバクターピロリ診断は、細菌感染の診断に使用されます。最も一般的な細菌感染症には、結核、クラミジア、淋病、その他の性感染症(STDs)などがあります。さらに、胃腸炎(一般に胃腸風邪として知られている)や尿路感染症(UTI)のような細菌感染症も流行しています。結核のような感染症も市場を牽引しています。世界保健機関(WHO)によると、2021年に世界で結核に罹患した推定患者数は1,060万人(95%UI:990万~1,100万人)で、2020年の1,010万人(95%UI:950万~1,070万人)から4.5%増加しています。このように、感染症の増加がヘリコバクターピロリ診断市場の成長を後押ししています。さらに、胃腸疾患の増加と診断技術の進歩が、市場に有利な機会を生み出す可能性があります。しかし、政府による厳しい規制規範は、2023年から2030年の予測期間を通じて市場の成長を妨げる可能性があります。

ヘリコバクターピロリ診断の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、確立されたヘルスケアインフラにより、2022年の市場を独占しました。この地域には、ピロリ菌診断を含む包括的な診断サービスを提供する診断ラボ、病院、ヘルスケア施設の強固なネットワークがあります。アジア太平洋地域は、ヘルスケア支出の増加により、予測期間中に最も急成長する地域と考えられています。人々の健康に対する意識が高まり、医療サービスへのアクセスが向上するにつれて、ピロリ菌診断を含む診断検査に対する需要が高まっています。この動向が市場の成長に寄与しています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 ヘリコバクターピロリ診断の世界市場定義とスコープ

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 ヘリコバクターピロリ診断の世界市場力学

  • ヘリコバクターピロリ診断市場の影響分析(2020-2030年)
    • 市場促進要因
      • 有病率の上昇
      • ピロリ菌感染に対する意識の高まり
    • 市場の課題
      • 政府による厳しい規制基準
    • 市場機会
      • 胃腸疾患の増加
      • 診断技術の進歩

第4章 ヘリコバクターピロリ診断の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 ヘリコバクターピロリ診断の世界市場:技術別

  • 市場スナップショット
  • ヘリコバクターピロリ診断の世界市場:技術別、実績 - ポテンシャル分析
  • ヘリコバクターピロリ診断の世界市場:技術別推定・予測、2020-2030年
  • ヘリコバクターピロリ診断市場、サブセグメント分析
    • 免疫測定法
    • POC
    • 分子診断

第6章 ヘリコバクターピロリ診断の世界市場:エンドユーザー別

  • 市場スナップショット
  • ヘリコバクターピロリ診断の世界市場:エンドユーザー別、実績 - ポテンシャル分析
  • ヘリコバクターピロリ診断の世界市場:エンドユーザー別推定・予測、2020-2030年
  • ヘリコバクターピロリ診断市場、サブセグメント分析
    • 病院
    • 診断研究所
    • クリニック

第7章 ヘリコバクターピロリ診断の世界市場:地域別分析

  • 主要国
  • 主な新興国
  • ヘリコバクターピロリ診断市場、地域別市場スナップショット
  • 北米
    • 米国
      • 技術の推定・予測、2020-2030年
      • エンドユーザーの推定・予測、2020-2030年
    • カナダ
  • 欧州ヘリコバクターピロリ診断市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋ヘリコバクターピロリ診断市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのヘリコバクターピロリ診断市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
      • 主要情報
      • 概要
      • 財務(データの入手可能性によります)
      • 製品概要
      • 最近の動向
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche Ltd.
    • Alpha Laboratories Ltd.
    • Biohit healthcare Ltd.
    • Meridian Bioscience Inc.
    • Quest Diagnostics
    • Coris BioConcept
    • Abbott Laboratories
    • Becton, Dickinson and Co.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Helicobacter Pylori Diagnostics Market , report scope
  • TABLE 2. Global Helicobacter Pylori Diagnostics Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3. Global Helicobacter Pylori Diagnostics Market estimates & forecasts by Technology 2020-2030 (USD Million)
  • TABLE 4. Global Helicobacter Pylori Diagnostics Market estimates & forecasts by End User 2020-2030 (USD Million)
  • TABLE 5. Global Helicobacter Pylori Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 6. Global Helicobacter Pylori Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Helicobacter Pylori Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Helicobacter Pylori Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Helicobacter Pylori Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Helicobacter Pylori Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Helicobacter Pylori Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Helicobacter Pylori Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Helicobacter Pylori Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. Global Helicobacter Pylori Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. U.S. Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16. U.S. Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 17. U.S. Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18. Canada Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 19. Canada Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 20. Canada Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21. UK Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 22. UK Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 23. UK Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24. Germany Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 25. Germany Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 26. Germany Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27. France Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 28. France Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 29. France Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30. Italy Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 31. Italy Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 32. Italy Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33. Spain Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 34. Spain Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 35. Spain Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36. RoE Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 37. RoE Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 38. RoE Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39. China Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 40. China Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 41. China Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42. India Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 43. India Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 44. India Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45. Japan Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 46. Japan Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 47. Japan Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48. South Korea Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 49. South Korea Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 50. South Korea Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51. Australia Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 52. Australia Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 53. Australia Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54. RoAPAC Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 56. RoAPAC Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57. Brazil Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 58. Brazil Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 59. Brazil Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60. Mexico Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 61. Mexico Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 62. Mexico Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63. RoLA Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 64. RoLA Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 65. RoLA Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66. Saudi Arabia Helicobacter Pylori Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 67. South Africa Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 68. RoMEA Helicobacter Pylori Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69. List of secondary sources, used in the study of global Helicobacter Pylori Diagnostics Market
  • TABLE 70. List of primary sources, used in the study of global Helicobacter Pylori Diagnostics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Helicobacter Pylori Diagnostics Market , research methodology
  • FIG 2. Global Helicobacter Pylori Diagnostics Market , Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Helicobacter Pylori Diagnostics Market , key trends 2022
  • FIG 5. Global Helicobacter Pylori Diagnostics Market , growth prospects 2023-2030
  • FIG 6. Global Helicobacter Pylori Diagnostics Market , porters 5 force model
  • FIG 7. Global Helicobacter Pylori Diagnostics Market , pest analysis
  • FIG 8. Global Helicobacter Pylori Diagnostics Market , value chain analysis
  • FIG 9. Global Helicobacter Pylori Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Helicobacter Pylori Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Helicobacter Pylori Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Helicobacter Pylori Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Helicobacter Pylori Diagnostics Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Helicobacter Pylori Diagnostics Market , regional snapshot 2020 & 2030
  • FIG 15. North America Helicobacter Pylori Diagnostics Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Helicobacter Pylori Diagnostics Market 2020 & 2030 (USD Million)
  • FIG 17. Asia pacific Helicobacter Pylori Diagnostics Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Helicobacter Pylori Diagnostics Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Helicobacter Pylori Diagnostics Market 2020 & 2030 (USD Million)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Helicobacter Pylori Diagnostics Market is valued at approximately USD 601.2 million in 2022 and is anticipated to grow with a healthy growth rate of more than 6% over the forecast period 2023-2030. The Helicobacter pylori diagnostics market refers to the segment focused on the utilization of diagnostic tests and devices specifically designed for the detection and identification of Helicobacter pylori (H. pylori) bacteria in patients. These diagnostics play a crucial role in identifying H. pylori infections, which are associated with various gastrointestinal disorders, including peptic ulcers, gastritis, and stomach cancer. The market encompasses a range of diagnostic methods such as serological tests, urea breath tests, stool antigen tests, and molecular diagnostics, which aid healthcare professionals in accurate and timely diagnosis, enabling appropriate treatment and management of H. pylori-related conditions. The Helicobacter pylori diagnostics market is being driven by factors such as the rising prevalence of the disease and rising awareness regarding H. pylori infections.

The Helicobacter Pylori Diagnostics is used in diagnosis bacterial infections. Some of the most common bacterial infections include Tuberculosis, Chlamydia, gonorrhea, as well as other sexually transmitted diseases (STDs). Additionally, bacterial infections like gastroenteritis (commonly known as stomach flu) and urinary tract infections (UTIs) are also prevalent. The infectious disease like tuberculosis is also driving the market, According to World Health Organization, estimated 10.6 million people (95% UI: 9.9-11 million) who fell ill with TB worldwide in 2021 is an increase of 4.5% from 10.1 million (95% UI: 9.5-10.7 million in 2020). Thus, rising infectious diseases fueling the growth for Helicobacter Pylori Diagnostics market. In addition to the rising gastrointestinal disorder and advancements in diagnostic technologies may create lucrative opportunities for the market. However, the stringent regulatory Norms by the government may hinder the growth of the market throughout the forecast period of 2023-2030.

The key regions considered for the Global Helicobacter Pylori Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the well-established healthcare infrastructure. The region has a robust network of diagnostic laboratories, hospitals, and healthcare facilities that provide comprehensive diagnostic services, including H. pylori diagnostics. Asia Pacific is considered the fastest growing region during the forecasted period due to the increasing healthcare expenditure. As people become more conscious of their health and have greater access to medical services, the demand for diagnostic tests, including H. pylori diagnostics, has risen. This trend contributes to the growth of the market.

Major market player included in this report are:

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Alpha Laboratories Ltd.
  • Biohit Healthcare Ltd.
  • Meridian Bioscience Inc.
  • Quest Diagnostics
  • Coris BioConcept
  • Abbott Laboratories
  • Becton, Dickinson and Co.

Recent Developments in the Market:

  • In May 2022, Biomerica, Inc. achieved the CE Mark for its hp+detect diagnostic test, designed to detect Helicobacter pylori bacteria. This significant milestone allows Biomerica to commence the marketing and sales of its hp+detect diagnostic test in the European Union (EU) and other international markets. The company proceed with registering the product in each country where it intends to sell, ensuring compliance with local regulations. This achievement positions Biomerica to address the diagnostic needs related to H. pylori infections in these regions, providing healthcare professionals with a reliable and efficient tool for detecting this bacterium.

Global Helicobacter Pylori Diagnostics Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Technology, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

  • Immunoassays
  • POC
  • Molecular Diagnostics

By End User:

  • Hospitals
  • Diagnostics Laboratories
  • Clinics

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Helicobacter Pylori Diagnostics Market , by Region, 2020-2030 (USD Million)
    • 1.2.2. Helicobacter Pylori Diagnostics Market , by Technology, 2020-2030 (USD Million)
    • 1.2.3. Helicobacter Pylori Diagnostics Market , by End User, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Helicobacter Pylori Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Helicobacter Pylori Diagnostics Market Dynamics

  • 3.1. Helicobacter Pylori Diagnostics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of disease.
      • 3.1.1.2. Rising awareness regarding H. pylori infections.
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent regulatory Norms by government.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising gastrointestinal disorder.
      • 3.1.3.2. Advancements in diagnostic technologies

Chapter 4. Global Helicobacter Pylori Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Helicobacter Pylori Diagnostics Market, by Technology

  • 5.1. Market Snapshot
  • 5.2. Global Helicobacter Pylori Diagnostics Market by Technology, Performance - Potential Analysis
  • 5.3. Global Helicobacter Pylori Diagnostics Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
  • 5.4. Helicobacter Pylori Diagnostics Market , Sub Segment Analysis
    • 5.4.1. Immunoassays
    • 5.4.2. POC
    • 5.4.3. Molecular Diagnostics

Chapter 6. Global Helicobacter Pylori Diagnostics Market, by End User

  • 6.1. Market Snapshot
  • 6.2. Global Helicobacter Pylori Diagnostics Market by End User, Performance - Potential Analysis
  • 6.3. Global Helicobacter Pylori Diagnostics Market Estimates & Forecasts by End User 2020-2030 (USD Million)
  • 6.4. Helicobacter Pylori Diagnostics Market , Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostics Laboratories
    • 6.4.3. Clinics

Chapter 7. Global Helicobacter Pylori Diagnostics Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Helicobacter Pylori Diagnostics Market , Regional Market Snapshot
  • 7.4. North America Helicobacter Pylori Diagnostics Market
    • 7.4.1. U.S. Helicobacter Pylori Diagnostics Market
      • 7.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Helicobacter Pylori Diagnostics Market
  • 7.5. Europe Helicobacter Pylori Diagnostics Market Snapshot
    • 7.5.1. U.K. Helicobacter Pylori Diagnostics Market
    • 7.5.2. Germany Helicobacter Pylori Diagnostics Market
    • 7.5.3. France Helicobacter Pylori Diagnostics Market
    • 7.5.4. Spain Helicobacter Pylori Diagnostics Market
    • 7.5.5. Italy Helicobacter Pylori Diagnostics Market
    • 7.5.6. Rest of Europe Helicobacter Pylori Diagnostics Market
  • 7.6. Asia-Pacific Helicobacter Pylori Diagnostics Market Snapshot
    • 7.6.1. China Helicobacter Pylori Diagnostics Market
    • 7.6.2. India Helicobacter Pylori Diagnostics Market
    • 7.6.3. Japan Helicobacter Pylori Diagnostics Market
    • 7.6.4. Australia Helicobacter Pylori Diagnostics Market
    • 7.6.5. South Korea Helicobacter Pylori Diagnostics Market
    • 7.6.6. Rest of Asia Pacific Helicobacter Pylori Diagnostics Market
  • 7.7. Latin America Helicobacter Pylori Diagnostics Market Snapshot
    • 7.7.1. Brazil Helicobacter Pylori Diagnostics Market
    • 7.7.2. Mexico Helicobacter Pylori Diagnostics Market
  • 7.8. Middle East & Africa Helicobacter Pylori Diagnostics Market
    • 7.8.1. Saudi Arabia Helicobacter Pylori Diagnostics Market
    • 7.8.2. South Africa Helicobacter Pylori Diagnostics Market
    • 7.8.3. Rest of Middle East & Africa Helicobacter Pylori Diagnostics Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Thermo Fisher Scientific Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Bio-Rad Laboratories Inc.
    • 8.3.3. F. Hoffmann-La Roche Ltd.
    • 8.3.4. Alpha Laboratories Ltd.
    • 8.3.5. Biohit healthcare Ltd.
    • 8.3.6. Meridian Bioscience Inc.
    • 8.3.7. Quest Diagnostics
    • 8.3.8. Coris BioConcept
    • 8.3.9. Abbott Laboratories
    • 8.3.10. Becton, Dickinson and Co.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption